-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Perspective Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2014 to 2024.
- Perspective Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $7.85M.
- Perspective Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$2.65M.
- Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was -$2.1M, a 20.9% increase from 2023.
- Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$2.65M.
- Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)